Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHLJoanna Zurko, Reem Karmali, Jane N. Winter et al.|Blood Advances|2022Cited by 50
Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patientsYoung Kwang Chae, Manali Bhave, Wade T. Iams et al.|Cancer Treatment Reviews|2017Cited by 47